Losartan Potassium and Hydrochlorothiazide
- Product NDC
- 50090-5113
- 11-digit product format
- 500905113
- Labeler code
- 50090
- Product ID
- 50090-5113_7d66d4bc-6299-43af-a065-c3dc6acf2572
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Losartan Potassium and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA078245
- Marketing category
- ANDA
- Marketing start
- 2010-10-06
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5113-0 | 50090511300 | 30 TABLET in 1 BOTTLE (50090-5113-0) | 30 tablet | 2020-07-30 | 0000-00-00 | No | No | Current |
| 50090-5113-1 | 50090511301 | 90 TABLET in 1 BOTTLE (50090-5113-1) | 90 tablet | 2020-07-30 | 0000-00-00 | No | No | Current |